Community Health Systems Inc (CYH) shareholders
Close on Nov 17, 2026Market cap $284.87MP/E 7.8Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Weitman Capital LLC Joint filing with Aaron Weitman (9.00%), CastleKnight Fund GP LLC (9.00%) and 3 more | 12,667,586 | 9.00% | 13G (passive) amendment | Mar 31, 2026 |
| Castleknight Master Fund LP Joint filing with Aaron Weitman (8.80%), Castleknight Fund Gp LLC (8.80%) and 3 more | 12,262,508 | 8.80% | 13G (passive) amendment | Sep 30, 2025 |
| Apollo Management Holdings, L.P. Joint filing with Apollo Capital Management GP, LLC (8.40%), Apollo Capital Management, L.P. (8.40%) and 1 more | 11,859,526 | 8.40% | 13G (passive) amendment | Jun 30, 2026 |
| Apollo Capital Management GP, LLC Joint filing with Apollo Capital Management, L.P. (8.20%), Apollo Management Holdings GP, LLC (8.20%) and 1 more | 11,489,316 | 8.20% | 13G (passive) amendment | Mar 31, 2026 |
| BlackRock, Inc. | 9,750,502 | 7.10% | 13G (passive) amendment | Dec 31, 2023 |
| CastleKnight Management LP Joint filing with Aaron Weitman (7.00%), CastleKnight Fund GP LLC (7.00%) and 3 more | 9,748,536 | 7.00% | 13G (passive) amendment | Dec 31, 2025 |
| CastleKnight Management GP LLC Joint filing with Aaron Weitman (6.80%), CastleKnight Fund GP LLC (6.80%) and 3 more | 9,401,740 | 6.80% | 13G (passive) amendment | Dec 31, 2024 |
| Kamran Moghtaderi Joint filing with Eversept 1 LLC (6.10%), Eversept Partners, L.P. (6.10%) | 8,458,020 | 6.10% | 13G (passive) amendment | Mar 31, 2025 |
| Eversept Partners, L.P. Joint filing with Eversept 1 LLC (5.73%), Kamran Moghtaderi (5.73%) | 7,943,802 | 5.73% | 13G (passive) amendment | Dec 31, 2025 |
| Wayne T. Smith | 7,837,614 | 5.70% | 13G (passive) amendment | Dec 31, 2023 |
| He Zhengxu | 7,410,784 | 5.30% | 13G (passive) | May 14, 2026 |
| Nomura Global Financial Products Inc Joint filing with Nomura Holdings Inc (5.20%) | 7,271,079 | 5.20% | 13G (passive) | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CYH | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| CastleKnight Management LP | 13,384,586 | 9.49% | $44.70M | +717,000 | 0.61% |
| Apollo Management Holdings, L.P. | 11,859,526 | 8.41% | $39.61M | +370,210 | 0.44% |
| BlackRock, Inc. | 10,930,538 | 7.75% | $36.51M | +1,127,681 | 0.00% |
| Eversept Partners, LP | 7,864,575 | 5.58% | $26.27M | −812,706 | 1.36% |
| Nomura Holdings Inc | 6,703,109 | 4.75% | $22.39M | −181,900 | 0.03% |
| Vanguard Capital Management LLC | 5,289,931 | 3.75% | $17.67M | −85,572 | 0.00% |
| Whitebox Advisors LLC | 3,732,743 | 2.65% | $12.47M | +604,859 | 0.16% |
| Geode Capital Management, LLC | 3,167,702 | 2.25% | $10.58M | +260,097 | 0.00% |
| State Street Corp | 3,061,863 | 2.17% | $10.23M | +139,953 | 0.00% |
| Vanguard Portfolio Management LLC | 3,018,598 | 2.14% | $10.08M | +25,102 | 0.00% |
| Saba Capital Management, L.P. | 2,882,169 | 2.04% | $9.63M | +1,600,330 | 0.25% |
| SG Americas Securities, LLC | 2,722,023 | 1.93% | $9.09M | +2,689,066 | 0.01% |
| Owl Creek Asset Management, L.P. | 2,530,622 | 1.79% | $8.45M | – | 0.70% |
| Charles Schwab Investment Management Inc | 2,448,018 | 1.74% | $8.18M | −311,186 | 0.00% |
| Dimensional Fund Advisors LP | 2,351,460 | 1.67% | $7.85M | −92,158 | 0.00% |
| D. E. Shaw & Co., Inc. | 2,344,128 | 1.66% | $7.83M | −24,388 | 0.00% |
| Aqr Capital Management LLC | 2,290,827 | 1.62% | $7.65M | +980,081 | 0.00% |
| Two Sigma Investments, LP | 2,205,336 | 1.56% | $7.37M | −795,070 | 0.01% |
| Diameter Capital Partners LP | 1,837,962 | 1.30% | $6.14M | New | 0.49% |
| Bank Of America Corp /De/ | 1,767,619 | 1.25% | $5.90M | +1,173,504 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 181 | 117M | 82.7% | 30 / 67 | 52 / 24 | 17M | 9M |
| Q1 2026 | 176 | 109M | 77.1% | 18 / 62 | 60 / 23 | 22M | 11M |
| Q4 2025 | 183 | 107M | 75.7% | 37 / 55 | 57 / 25 | 12M | 16M |
| Q3 2025 | 173 | 112M | 79.1% | 27 / 55 | 58 / 28 | 17M | 21M |
| Q2 2025 | 175 | 115M | 81.9% | 28 / 65 | 47 / 22 | 16M | 16M |
| Q1 2025 | 170 | 115M | 81.8% | 22 / 53 | 59 / 35 | 20M | 20M |
| Q4 2024 | 187 | 116M | 82.2% | 28 / 61 | 58 / 31 | 29M | 20M |
| Q3 2024 | 191 | 107M | 76.1% | 28 / 59 | 63 / 24 | 26M | 15M |
| Q2 2024 | 190 | 106M | 75.5% | 35 / 62 | 45 / 30 | 17M | 19M |
| Q1 2024 | 187 | 108M | 76.7% | 25 / 60 | 58 / 31 | 20M | 14M |
| Q4 2023 | 193 | 102M | 72.6% | 49 / 61 | 53 / 39 | 26M | 29M |
| Q3 2023 | 186 | 105M | 74.6% | 23 / 49 | 75 / 33 | 10M | 10M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
140 funds held CYH in Q2 2026, 60% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CYH | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3,813,888 | 2.70% | $12.74M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 3,488,937 | 2.47% | $11.65M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 1,417,416 | 1.01% | $3.95M | 0.01% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 1,347,631 | 0.96% | $4.50M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 1,230,623 | 0.87% | $4.11M | 0.03% | Jun 30, 2026 |
| Schwab Fundamental U.S. Large Company ETF | 1,126,552 | 0.80% | $3.06M | 0.01% | May 31, 2026 |
| PIMCO RAE US Small Fund | 994,208 | 0.70% | $3.32M | 0.09% | Jun 30, 2026 |
| Vanguard Explorer Fund | 768,760 | 0.55% | $2.14M | 0.01% | Jul 31, 2026 |
| Vanguard Strategic Equity Fund | 737,087 | 0.52% | $2.46M | 0.02% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 657,416 | 0.47% | $1.79M | 0.01% | May 31, 2026 |
| U.S. Small Cap Portfolio | 609,167 | 0.43% | $1.70M | 0.01% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 575,466 | 0.41% | $1.57M | 0.00% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 546,576 | 0.39% | $1.49M | 0.01% | May 31, 2026 |
| U.S. Micro Cap Portfolio | 473,828 | 0.34% | $1.32M | 0.02% | Jul 31, 2026 |
| Schwab Fundamental U.S. Large Company Index Fund | 459,234 | 0.33% | $1.28M | 0.01% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Tim Hingtgen | CEO, Director | 1,267,588 | 0.90% | Mar 3, 2025 |
| David V. Rice | EVP-Clinical Operations & CMO | 30,000 | 0.02% | Jun 1, 2026 |
| Jason K. Johnson | EVP & CFO | 202,049 | 0.14% | Mar 3, 2026 |
| Kevin J. Hammons | CEO | 992,441 | 0.70% | Mar 3, 2026 |
| Kevin A. Stockton | EVP, Operations & Development | 213,863 | 0.15% | Mar 3, 2026 |
| Justin D. Pitt | Pres,Chief Legal&Admin Officer | 300,334 | 0.21% | Mar 3, 2026 |
| Phillip A. Posey | SVP & CAO | 52,924 | 0.04% | Mar 3, 2026 |
| Miguel S. Benet | President and CMO | 47,635 | 0.03% | Mar 3, 2025 |
| Austen D. Mason | Regional President | 142,500 | 0.10% | Mar 3, 2025 |
| Mark B. Medley | Regional President | 128,637 | 0.09% | Mar 3, 2025 |
| Chad A. Campbell | Regional President | 150,787 | 0.11% | Mar 3, 2025 |
| William Norris Jennings | Director | 38,468 | 0.03% | Aug 25, 2026 |
| K. Ranga Krishnan | Director | 170,023 | 0.12% | Jun 30, 2026 |
| Ronald L. Burgess Jr | Director | 0 | – | Mar 3, 2026 |
| John A. Clerico | Director | 368,763 | 0.26% | Mar 3, 2026 |
| John A. Fry | Director | 268,966 | 0.19% | Mar 3, 2026 |
| Michael Dinkins | Director | 204,976 | 0.15% | Mar 3, 2026 |
| Fawn D. Lopez | Director | 0 | – | Mar 3, 2026 |
| James S. Ely III | Director | 377,027 | 0.27% | Mar 3, 2026 |
| Wayne T. Smith | Director | 7,306,142 | 5.18% | Mar 3, 2026 |
| Hubert James Williams | Director | 171,024 | 0.12% | Mar 3, 2026 |
| Elizabeth T. Hirsch | Director | 142,126 | 0.10% | Mar 3, 2026 |
| Joseph Arthur Hastings | Director | 17,130 | 0.01% | Mar 3, 2026 |
| Susan W. Brooks | Director | 67,856 | 0.05% | Mar 3, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| William Norris Jennings Director | Aug 25, 2026 | Sale | −40,000 | $2.96 | $118.40K | 38,468 |
| K. Ranga Krishnan Director | Jun 30, 2026 | Option exercise | +13,930 | – | – | 170,023 |
| David V. Rice EVP-Clinical Operations & CMO | Jun 1, 2026 | Award | +30,000 | – | – | 30,000 |
| K. Ranga Krishnan Director | Apr 22, 2026 | Option exercise | +46,950 | – | – | 156,093 |
| Wayne T. Smith Director | Mar 2, 2026 | Gift | −19,400 | – | – | 5,217,579 |
| Michael Dinkins Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 204,976 |
| Michael Dinkins Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 225,882 |
| Justin D. Pitt Pres,Chief Legal&Admin Officer | Mar 1, 2026 | Tax withholding | −24,922 | $3.46 | $86.23K | 287,750 |
| Justin D. Pitt Pres,Chief Legal&Admin Officer | Mar 1, 2026 | Award | +40,000 | – | – | 312,672 |
| Justin D. Pitt Pres,Chief Legal&Admin Officer | Mar 1, 2026 | Option exercise | +30,000 | – | – | 272,672 |
| John A. Fry Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 268,966 |
| John A. Fry Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 249,033 |
| John A. Fry Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 228,127 |
| John A. Clerico Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 368,763 |
| John A. Clerico Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 348,830 |
| John A. Clerico Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 327,924 |
| Phillip A. Posey SVP & CAO | Mar 1, 2026 | Award | +25,000 | – | – | 52,924 |
| Phillip A. Posey SVP & CAO | Mar 1, 2026 | Tax withholding | −1,188 | $3.46 | $4.11K | 51,736 |
| Elizabeth T. Hirsch Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 142,126 |
| Elizabeth T. Hirsch Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 121,220 |
| Elizabeth T. Hirsch Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 162,059 |
| Susan W. Brooks Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 67,856 |
| Susan W. Brooks Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 88,762 |
| Susan W. Brooks Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 108,695 |
| James S. Ely III Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 372,037 |
| James S. Ely III Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 392,943 |
| James S. Ely III Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 412,876 |
| Jason K. Johnson EVP & CFO | Mar 1, 2026 | Option exercise | +30,000 | – | – | 202,049 |
| Jason K. Johnson EVP & CFO | Mar 1, 2026 | Tax withholding | −23,610 | $3.46 | $81.69K | 268,439 |
| Jason K. Johnson EVP & CFO | Mar 1, 2026 | Award | +90,000 | – | – | 292,049 |
| Kevin J. Hammons CEO | Mar 1, 2026 | Award | +200,000 | – | – | 992,441 |
| Kevin J. Hammons CEO | Mar 1, 2026 | Tax withholding | −96,896 | $3.46 | $335.26K | 895,545 |
| Kevin J. Hammons CEO | Mar 1, 2026 | Option exercise | +156,240 | – | – | 792,441 |
| Hubert James Williams Director | Mar 1, 2026 | Option exercise | +9,756 | – | – | 171,024 |
| Hubert James Williams Director | Mar 1, 2026 | Option exercise | +19,933 | – | – | 211,863 |
| Hubert James Williams Director | Mar 1, 2026 | Option exercise | +20,906 | – | – | 191,930 |
| Kevin A. Stockton EVP, Operations & Development | Mar 1, 2026 | Option exercise | +50,000 | – | – | 213,863 |
| Kevin A. Stockton EVP, Operations & Development | Mar 1, 2026 | Award | +30,000 | – | – | 243,863 |
| Kevin A. Stockton EVP, Operations & Development | Mar 1, 2026 | Tax withholding | −35,573 | $3.46 | $123.08K | 208,290 |
| James S. Ely III Director | Dec 31, 2025 | Option exercise | +2,882 | – | – | 362,281 |
| Susan W. Brooks Director | Jun 1, 2025 | Option exercise | +5,894 | – | – | 58,100 |
| James S. Ely III Director | Mar 1, 2025 | Option exercise | +20,906 | – | – | 359,399 |
| James S. Ely III Director | Mar 1, 2025 | Option exercise | +9,756 | – | – | 338,493 |
| James S. Ely III Director | Mar 1, 2025 | Option exercise | +5,894 | – | – | 328,737 |
| Hubert James Williams Director | Mar 1, 2025 | Option exercise | +5,894 | – | – | 130,606 |
| Hubert James Williams Director | Mar 1, 2025 | Option exercise | +20,906 | – | – | 161,268 |
| Hubert James Williams Director | Mar 1, 2025 | Option exercise | +9,756 | – | – | 140,362 |
| Michael Dinkins Director | Mar 1, 2025 | Option exercise | +5,894 | – | – | 164,558 |
| Michael Dinkins Director | Mar 1, 2025 | Option exercise | +20,906 | – | – | 195,220 |
| Michael Dinkins Director | Mar 1, 2025 | Option exercise | +9,756 | – | – | 174,314 |
| Austen D. Mason Regional President | Mar 1, 2025 | Award | +25,000 | – | – | 142,500 |
| Austen D. Mason Regional President | Mar 1, 2025 | Option exercise | +10,500 | – | – | 117,500 |
| Elizabeth T. Hirsch Director | Mar 1, 2025 | Option exercise | +5,894 | – | – | 80,802 |
| Elizabeth T. Hirsch Director | Mar 1, 2025 | Option exercise | +20,906 | – | – | 111,464 |
| Elizabeth T. Hirsch Director | Mar 1, 2025 | Option exercise | +9,756 | – | – | 90,558 |
| Mark B. Medley Regional President | Mar 1, 2025 | Tax withholding | −15,682 | $3.01 | $47.20K | 128,637 |
| Mark B. Medley Regional President | Mar 1, 2025 | Award | +25,000 | – | – | 144,319 |
| Mark B. Medley Regional President | Mar 1, 2025 | Option exercise | +10,500 | – | – | 119,319 |
| Susan W. Brooks Director | Mar 1, 2025 | Option exercise | +9,756 | – | – | 31,300 |
| Susan W. Brooks Director | Mar 1, 2025 | Option exercise | +20,906 | – | – | 52,206 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Community Health Systems's stock actually held short. Settlement fails (shares not delivered on time) peaked at 13,000 shares on Sep 18, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| William Norris Jennings Director | Aug 25, 2026 | 40,000 | $120.00K | Aug 25, 2026 | RSU Vest |
| Tim Hingtgen former CEO | Dec 9, 2025 | 66,666 | $225.66K | Dec 9, 2025 | stock option |
| Tim Hingtgen former CEO | Oct 28, 2025 | 532,813 | $2.23M | Oct 28, 2025 | RSU |
| Miguel S. Benet Officer | Feb 25, 2025 | 23,875 | $84.04K | Feb 21, 2025 | RSA Vest |
| Rebecca Pitt Officer, spouse is officer | Aug 7, 2023 | 9,068 | $54.40K | Aug 7, 2023 | RSU vest |
See a number that looks wrong?